Monday, January 19, 2026 – Closed
In observance of Martin Luther King Jr. Day.
As of the afternoon of January 23, 2025, our phones are operational. Thank you for your patience as our phone provider experienced a national outage that impacted our phone services on the afternoon of January 22 and the morning of January 23.
Cancer cells each carry specialized proteins or molecules that signal for the growth and division of the cells. Molecularly targeted agents are designed to block these specific molecules and prevent the messages telling the cell to grow or divide from being transmitted. This inhibits the growth of the cancer cells, ultimately resulting in their death. In most cases, each molecularly targeted agent is effective against a single protein or molecule. Specialized genetic and molecular testing of the cancer cells helps physicians determine whether a particular cancer is likely to respond to the targeted agent based on the presence or absence of the target protein in or on the cells. Molecularly targeted agents can be used alone or in combination with chemotherapy.
Molecularly targeted therapy is the cornerstone of precision medicine, a form of medicine that uses information about a person’s genes and proteins to prevent, diagnose, and treat disease.
They are relatively new in cancer treatment, and not all cancers carry a protein that is the target of the currently available drugs. At Bardmoor Cancer Center, our oncology specialists offer genetic testing and molecular profiling of the tumor cells to assess candidacy for targeted therapies and tailor a unique and precise treatment plan specifically for you.
Unlike chemotherapy agents which are indiscriminate and kill all rapidly dividing cells including some healthy cells, molecularly targeted agents selectively kill only those cells carrying the target protein. Consequently, they effectively treat the cancer with significantly fewer side effects.
Cancer cells each carry specialized proteins or molecules that signal for the growth and division of the cells. Molecularly targeted agents are designed to block these specific molecules and prevent the messages telling the cell to grow or divide from being transmitted. This inhibits the growth of the cancer cells, ultimately resulting in their death. In most cases, each molecularly targeted agent is effective against a single protein or molecule. Specialized genetic and molecular testing of the cancer cells helps physicians determine whether a particular cancer is likely to respond to the targeted agent based on the presence or absence of the target protein in or on the cells. Molecularly targeted agents can be used alone or in combination with chemotherapy.
Molecularly targeted therapy is the cornerstone of precision medicine, a form of medicine that uses information about a person’s genes and proteins to prevent, diagnose, and treat disease.
They are relatively new in cancer treatment, and not all cancers carry a protein that is the target of the currently available drugs. At Bardmoor Cancer Center, our oncology specialists offer genetic testing and molecular profiling of the tumor cells to assess candidacy for targeted therapies and tailor a unique and precise treatment plan specifically for you.
Unlike chemotherapy agents which are indiscriminate and kill all rapidly dividing cells including some healthy cells, molecularly targeted agents selectively kill only those cells carrying the target protein. Consequently, they effectively treat the cancer with significantly fewer side effects.